SEC Form 4 · accession 0000874015-17-000020
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Spencer R Berthelsen
Director
Period of report
Feb 24, 2017
Accepted (ET)
Feb 27, 2017 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 24, 2017 | M | 12,500 | $9.77 | A | 88,958 | D | |
| Common StockF2 | holding | — | — | — | 70 | I | By Daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) | $9.77 | Feb 24, 2017 | M | 12,500 | D | Jul 2, 2011 | Jul 1, 2017 | Common Stock | 12,500 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option that was scheduled to expire on 7/1/2017.
- F2The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.